NCT00367770 - BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Tracleer®

Patients will receive up to 125 mg b.i.d. of Tracleer.

Trial Locations (17)

3050

The Royal Melbourne Hospital, Victoria

27100

San Matteo Hospital, Pavia

28046

Unidad Medico Quirurgica de Cardiologia - Edificio General, Madrid

40138

University of Bologna, Bologna

75007

Hospital Necker-Enfants Malades, Paris

02115

BACH Pulmonary Hypertension Service, Boston

77030-2303

Texas Children's Hospital, Houston

NSW 2050

Royal Prince Alfred Hospital - Central Clinical School, Camperdown

AT-1090

Universitatsklinikum fur Innere Medizin II, Vienna

BE-3000

UZ Gasthuisberg, Leuven

T1Y 6J4

The Peter Lougheed Centre, Calgary

M5G 2C4

Toronto General Hospital, Toronto

D-32545

Herzzentrum NRW, Bad Oeynhausen

D-80636

Deutsches Herzzentrum Munchen, München

9713 GZ

Academisch Ziekenhuis Groningen, Groningen

G11 6NT

Scottish Vascular Unit - Western Infirmary, Glasgow

SW3 6NP

Royal Brompton Hospital, London